These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 23529336)

  • 1. Current drug targets for helminthic diseases.
    Rana AK; Misra-Bhattacharya S
    Parasitol Res; 2013 May; 112(5):1819-31. PubMed ID: 23529336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plant products in the treatment and control of filariasis and other helminth infections and assay systems for antifilarial/anthelmintic activity.
    Murthy PK; Joseph SK; Murthy PS
    Planta Med; 2011 Apr; 77(6):647-61. PubMed ID: 20957596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worms--a "license to kill".
    Kaminsky R; Rufener L; Bouvier J; Lizundia R; Schorderet Weber S; Sager H
    Vet Parasitol; 2013 Aug; 195(3-4):286-91. PubMed ID: 23664156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthelmintic metabolism in parasitic helminths: proteomic insights.
    Brophy PM; MacKintosh N; Morphew RM
    Parasitology; 2012 Aug; 139(9):1205-17. PubMed ID: 22776506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthelmintic resistance in human helminths: a review.
    Geerts S; Gryseels B
    Trop Med Int Health; 2001 Nov; 6(11):915-21. PubMed ID: 11703846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HelmCoP: an online resource for helminth functional genomics and drug and vaccine targets prioritization.
    Abubucker S; Martin J; Taylor CM; Mitreva M
    PLoS One; 2011; 6(7):e21832. PubMed ID: 21760913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of enzymes that have helminth-specific active sites and are required for Rhodoquinone-dependent metabolism as targets for new anthelmintics.
    Lautens MJ; Tan JH; Serrat X; Del Borrello S; Schertzberg MR; Fraser AG
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009991. PubMed ID: 34843467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular aspects of drug resistance in parasitic helminths.
    Roos MH; Kwa MS; Veenstra JG; Kooyman FN; Boersema JH
    Pharmacol Ther; 1993 Nov; 60(2):331-6. PubMed ID: 8022863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing the gut microbiome in the fight against anthelminthic drug resistance.
    Sharpton TJ; Combrink L; Arnold HK; Gaulke CA; Kent M
    Curr Opin Microbiol; 2020 Feb; 53():26-34. PubMed ID: 32114334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemistry and pharmacology of neglected helminthic diseases.
    Müllner A; Helfer A; Kotlyar D; Oswald J; Efferth T
    Curr Med Chem; 2011; 18(5):767-89. PubMed ID: 21182483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic analyses of aminoacyl tRNA synthetases from human-infecting helminths.
    Goel P; Parvez S; Sharma A
    BMC Genomics; 2019 May; 20(1):333. PubMed ID: 31046663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance in human helminths: current situation and lessons from livestock.
    Geerts S; Gryseels B
    Clin Microbiol Rev; 2000 Apr; 13(2):207-22. PubMed ID: 10755998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of medicinal research in helminth diseases.
    Singh SK; Sharma S
    Med Res Rev; 1991 Nov; 11(6):581-615. PubMed ID: 1762474
    [No Abstract]   [Full Text] [Related]  

  • 14. Overcoming drug resistance for macro parasites.
    Srivastava M; Misra-Bhattacharya S
    Future Microbiol; 2015; 10(11):1783-9. PubMed ID: 26517758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A research agenda for helminth diseases of humans: intervention for control and elimination.
    Prichard RK; Basáñez MG; Boatin BA; McCarthy JS; García HH; Yang GJ; Sripa B; Lustigman S
    PLoS Negl Trop Dis; 2012; 6(4):e1549. PubMed ID: 22545163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective mechanisms of helminths against reactive oxygen species are highly promising drug targets.
    Perbandt M; Ndjonka D; Liebau E
    Curr Med Chem; 2014; 21(15):1794-808. PubMed ID: 24251574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human gastrointestinal helminth infections: are they now neglected diseases?
    Horton J
    Trends Parasitol; 2003 Nov; 19(11):527-31. PubMed ID: 14580965
    [No Abstract]   [Full Text] [Related]  

  • 18. Benzimidazole resistance in helminths: From problem to diagnosis.
    Furtado LFV; de Paiva Bello ACP; Rabelo ÉML
    Acta Trop; 2016 Oct; 162():95-102. PubMed ID: 27338184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin and its derivatives in treating helminthic infections beyond schistosomiasis.
    Lam NS; Long X; Su XZ; Lu F
    Pharmacol Res; 2018 Jul; 133():77-100. PubMed ID: 29727708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for the use of anthelmintics in livestock and their implications for the development of drug resistance.
    Michel JF
    Parasitology; 1985 Apr; 90 ( Pt 4)():621-8. PubMed ID: 3892435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.